Back to STATE STREET CORP STATE STREET CORP

IKTIKT
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in INHIBIKASE THERAPEUTICS INC

STATE STREET CORP holds 1.9M shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $3.9M as of 2026-Q2. The position was increased (+13.2% shares). IKT represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$3.9M

Current Shares

1.9M

Total Value Change

+$3.9M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+13.2%
$3.9M0.0%$2.03
30
2026-Q1
Increased
1.7M
+203.8%
$2.8M0.0%$1.91
42
2025-Q4
Increased
554,849
+9.3%
$1.1M0.0%$1.97
19
2025-Q3
Increased
507,749
+27.6%
$822,5530.0%$1.53
21
2025-Q2
Increased
397,812
+849.8%
$775,7330.0%$1.62
27
2025-Q1
Unchanged
41,884
0.0%
$91,7260.0%$2.29
0
2024-Q4
Increased
41,884
+315.4%
$136,1230.0%$3.24
24
2024-Q3
Unchanged
10,084
0.0%
$13,1090.0%$1.17
0

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used